Aerosol preparation of intact lipoproteins
View Patent ↗A medical diagnostic method and instrumentation system for analyzing noncovalently bonded agglomerated biological particles is described. The method and system comprises: a method of preparation for the biological particles; an electrospray generator; an alpha particle radiation source; a differential mobility analyzer; a particle counter; and data acquisition and analysis means. The medical device is useful for the assessment of human diseases, such as cardiac disease risk and hyperlipidemia, by rapid quantitative analysis of lipoprotein fraction densities. Initially, purification procedures are described to reduce an initial blood sample to an analytical input to the instrument. The measured sizes from the analytical sample are correlated with densities, resulting in a spectrum of lipoprotein densities. The lipoprotein density distribution can then be used to characterize cardiac and other lipid-related health risks.
1. An aerosol preparation of intact lipoprotein particles in an aqueous buffer at near neutral pH, comprising lipoprotein particles in a single positive charge state, wherein the lipoprotein particles are isolated from a physiological sample.
2. The preparation of claim 1 , wherein the lipoprotein particles are prepared from lipoproteins isolated from a single patient.
3. The preparation of claim 2 , wherein the lipoprotein particles comprise at least one lipoprotein selected from the group consisting of VLDL, IDL, LDL, HDL and chylomicrons.
4. The preparation of claim 2 , wherein the lipoprotein particles are prepared from lipoproteins isolated from a blood, a serum or a plasma of the patient.
5. An aerosol preparation of intact lipoprotein particles in an aqueous buffer at near neutral pH, comprising lipoprotein particles in more than a single positive charge state, wherein the lipoprotein particles are isolated from a physiological sample.
6. The aerosol preparation of claim 5 , wherein the lipoprotein particles are prepared from lipoproteins isolated from a single patient.
7. The aerosol preparation of claim 6 , wherein the lipoprotein particles are selected from the group consisting of VLDL, IDL, LDL, HDL, and chylomicrons.
8. The aerosol preparation of claim 6 , wherein the lipoprotein particles are prepared from lipoproteins isolated from a blood, a serum, or a plasma of the patient.